Sign in
Taking peoplePhase 4

Ferinject compared with Venofer for iron deficiency anemia in pregnancy

Compares Ferinject and Venofer in pregnant women with iron deficiency anemia.

Key facts

Who runs it
Western Galilee Hospital-Nahariya
Where
Israel1 site in 1 countryChoose a country to see its sites
Trial code
Registry title
Comparison Between Outcomes of Pregnant Women Treated With Ferinject vs. Venofer for Iron Deficiency Anemia
Status
Recruiting
Phase
Phase 4
People taking part
200 people, planned
Started
2 Nov 2023
Expected to end
Dec 2027
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Venofer 200 MG Per 10 ML Injection
  • Ferinject
Record updated
11 September 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for pregnant women past 24 weeks with low blood iron causing anemia. It compares two iron drips, Venofer and Ferinject.

Age
18 Years to 50 Years
Sex
Women only
Disease stage
Pregnancy beyond 24 weeks. Iron deficiency anemia with Hb below 9, or below 9.5 if the anemia causes symptoms or there was heavy bleeding after an earlier birth.
Earlier treatment
No iron given into a vein (IV iron) in the last month.
Biomarker or test result
Hemoglobin (Hb) below 9 gr/dl, or below 9.5 with symptoms or a past heavy bleed after birth.

Main reasons for not taking part

  • Allergy to one of the study drugs
  • IV iron treatment in the last month
  • Other conditions linked to anemia, such as thalassemia Major, kidney failure, or spherocytosis
  • Pregnancy with twins
  • Anemia not caused by low iron

This trial only enrols pregnant participants. The registry sentence this rests on: pregnancy>24 weeks of gestation anemia with Hb<9 anemia with Hb<9.5 if symptomatic anemia or previous postpartum hemorrhage

The registry criteria, word for word

Show all 6 criteriaShow less

Who can take part

  • pregnancy>24 weeks of gestation anemia with Hb<9 anemia with Hb<9.5 if symptomatic anemia or previous postpartum hemorrhage

Who cannot take part

  • Allergy to one of the study's drugs
  • Underlying medical conditions associated with anemia, such as thalassemia Major, renal insufficiency, or spherocytosis
  • IV iron treatment in the last month
  • Twin pregnancy
  • non iron deficiency anemia

The main criteria, as questions

These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Are you between 18 and 50 years old?

This trial is currently available in Israel.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The purpose of this study is to compare maternal outcomes such as increased hemoglobin need for blood transfusion and hemoglobin level before and post partum in women with hemoglobin <9 gr/dl , treated with venofer and women treated with ferinject.

The 2 groups in the trial

  • venoferExisting treatment, for comparison

    Women with iron def. anemia aith hemoglobin level \<9 gr/dl who will be traeted with venofer

    Treatment: Venofer 200 MG Per 10 ML Injection

  • FerinjectExisting treatment, for comparison

    Women with iron def. anemia aith hemoglobin level \<9 gr/dl who will be traeted with ferinject

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Comparison Between Outcomes of Pregnant Women Treated With Ferinject vs. Venofer for Iron Deficiency Anemia (Hb<9)
Plain-language title
Ferinject compared with Venofer for iron deficiency anemia in pregnancyGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 15 November 2026.
Criteria questions
Built from NCT06061393, who can take part
Record updated
11 September 2026